Skip to main content

ADVERTISEMENT

Antonio Sisinni, MD

Mid-Term Clinical Outcomes Following Percutaneous Mitral Valve Edge-to-Edge Repair
12/01/2020
Approximately 50% of patients with severe mitral regurgitation referred for surgery have prohibitive surgical risk. MitraClip (Abbott Vascular) is an alternative therapy option in these patients. The aim of this study is to evaluate mid-term...
Approximately 50% of patients with severe mitral regurgitation referred for surgery have prohibitive surgical risk. MitraClip (Abbott Vascular) is an alternative therapy option in these patients. The aim of this study is to evaluate mid-term...
Approximately 50% of patients...
12/01/2020
Journal of Invasive Cardiology